Posted inAsset managers

Janus Henderson sees good news ahead for active investors

There is more to equities than the Magnificent 7, argues the asset manager.
Linda Csellak has managed the Manulife fund since 2010. She has 21 years of Asian equity investment experience, most of it in small caps, making her one of the most experienced managers in the category, Share said. While she is supported by one small-cap analyst and ten portfolio managers and country specialists, “she is very hands-on with stock research”, Share noted. “The concern we have here is that [the analysts] are country specialists, not necessarily focused on small-cap research,” she said, adding that this tends to be common for small cap funds. “While the investment process seems sensible, we need more time to gain comfort around how Csellak and the small-cap analyst qualitatively stay on top of a diversified portfolio with a high annual portfolio turnover of 200% -- 300%,” Share wrote. The Templeton fund is managed by three portfolio managers: Chetan Sehgal, Vikas Chiranewal and Erman Kalkandelen. The first two led the fund since its inception and Kalkandelen joined in 2015. “Chetan is the key strength of the team,” said Share. “He can give a very clear and detailed investment case for each stock. He consistently impressed us.” The managers are supported by one of the largest emerging markets research teams of 51 portfolio managers and analysts located around the world. “This gives the team a very broad coverage of the small cap universe.” The two senior managers have other involvements beyond the Asian Smaller Companies Fund. Sehgal is director of the firm’s global emerging markets strategy and Chiranewal managers two onshore Indian funds: the Templeton India Equity Income Fund and the Templeton India Growth Fund.

A changing macroeconomic backdrop could create new pockets of leadership in global equity markets, according to Janus Henderson’s head of Americas equities Marc Pinto and head of EMEA and Asia Pacific equities Lucas Klein.

The dominance of the Magnificent Seven tech stocks could give way to new market dynamics this year 2025 as valuations diverge, geopolitical uncertainty grows, and policymakers focus on balancing inflation and growth, they write in their 2025 outlook.

Expectations have grown that president-elect Donald Trump will introduce a more business-friendly environment – from lower corporate tax rates to deregulation – that could propel domestic economic growth. In addition, the Federal Reserve is still projected to make two additional 25 basis point cuts by mid-2025.

Concurrently, many non-US markets are also pursuing policies to drive growth and/or anticipate geopolitical changes, while the effects of artificial intelligence on the broader economy, create investment opportunities that go beyond the Magnificent Seven.

“All of this could be good news for active investors,” argued Janus Henderson.

Their research shows that when the S&P 500 EW has outperformed the cap-weighted S&P 500 Index over a one-year period, the top-performing quartile of actively managed, large-blend US equity funds has also outperformed 93% of the time. Similar advantages continued over three- and five-year periods.

An area of their particular appeal is small caps.

“Historically, small- and mid-size firms tend to outperform during periods of declining rates since these companies often have levered balance sheets and therefore benefit from lower interest expense, boosting earnings. Reduced borrowing costs can also spur mergers and acquisitions or help minimize concerns about company liquidity,” Pinto and Klein write.

Meanwhile, the relative outperformance of large caps could also be getting “long in the tooth”. In the past, cycles of large- and small-cap outperformance typically alternate every six to 14 years, they note, yet the current run of large-cap dominance is butting up against the far end of that range.

Small caps also have large weightings in industrials and materials and could benefit from the onshoring of supply chains. And globally, small caps now trade at relatively attractive valuations.

In addition, innovation is opening up new end markets, including in non-tech sectors such as healthcare. Improvements in scientific understanding and research tools are leading to the launch of groundbreaking products, such as GLP-1s for obesity.

“It’s just one example of the many innovations that we think could drive returns in the year ahead and lead to a more dynamic playing field for equity investors,” write Pinto and Klein.

Part of the Mark Allen Group.